Kroemer G, Moreno de Alborán I, Gonzalo J A, Martínez C
Centro de Biología Molecular (CSIC), Universidad Autónoma de Madrid, Spain.
Crit Rev Immunol. 1993;13(2):163-91.
The study of cytokine biology relevant to the in vivo (patho)physiology of the immune response is complicated by a series of features inherent to the cytokine system. The present survey focuses on the mechanisms governing the function of cytokines that may give rise to methodological and conceptual problems concerning in vivo manipulations of immunologically relevant cytokines. Special emphasis is laid on the complex interrelation between individual cytokines (cascades, synergy, anergy, pleiotropism, and redundancy), as well as on the mechanisms that guarantee a compartmentalization of cytokines, i.e., a chronological, spatial, cell-type differentiation stage, and activation-dependent restriction of their function. The in vivo effects of cytokines can be studied either by augmenting their concentration or reducing their bioavailability. The advantages of local and systemic cytokine injections, usage of transgenes, or expression as gene products encoded by recombinant viruses are discussed and contrasted with different manipulations provoking cytokine deficiencies, namely the application of cytokine antagonists, neutralizing antibodies and receptor derivates, receptor-targeted cytotoxic drugs, and germ line disruption of cytokine genes. Both types of intervention are afflicted with major problems. Whereas providing an excess of cytokines in vivo, especially at the systemic level, constitutes an essentially non-physiological intervention, the induction of cytokine deficiencies will only unravel essential effects, but is incapable of elucidating the many pleiotropic cytokine effects that, by virtue of the redundancy of the system, compensate for each other.
细胞因子生物学与免疫反应的体内(病理)生理学相关的研究因细胞因子系统固有的一系列特征而变得复杂。本综述聚焦于调控细胞因子功能的机制,这些机制可能引发与免疫相关细胞因子体内操作有关的方法学和概念性问题。特别强调了单个细胞因子之间的复杂相互关系(级联、协同、无反应性、多效性和冗余性),以及保证细胞因子分隔化的机制,即其功能在时间、空间、细胞类型分化阶段以及激活依赖性方面的限制。细胞因子的体内效应可以通过增加其浓度或降低其生物利用度来研究。讨论了局部和全身注射细胞因子、使用转基因或表达重组病毒编码的基因产物的优点,并将其与引发细胞因子缺乏的不同操作进行了对比,这些操作包括应用细胞因子拮抗剂、中和抗体和受体衍生物、受体靶向细胞毒性药物以及细胞因子基因的种系破坏。这两种干预方式都存在重大问题。在体内提供过量的细胞因子,尤其是在全身水平,本质上是一种非生理性干预,而诱导细胞因子缺乏虽然只能揭示基本效应,但无法阐明细胞因子的许多多效性效应,由于该系统的冗余性,这些效应会相互补偿。